Evolving changes in M-protein and hemoglobin as predictors for progression of smoldering multiple myeloma

Blood Cancer J. 2018 Nov 8;8(11):107. doi: 10.1038/s41408-018-0144-x.

Affiliations

¹ Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
² Department of Cancer Biostatistics, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
³ Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA. manisha.bhutani@atriumhealth.org.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Biomarkers
Disease Progression
Female
Follow-Up Studies
Hemoglobins* / metabolism
Humans
Incidence
Male
Middle Aged
Myeloma Proteins* / metabolism
Prognosis
Proportional Hazards Models
Risk Factors
Smoldering Multiple Myeloma / blood*
Smoldering Multiple Myeloma / diagnosis*
Smoldering Multiple Myeloma / epidemiology
Smoldering Multiple Myeloma / mortality

Substances

Biomarkers
Hemoglobins
Myeloma Proteins
multiple myeloma M-proteins